Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001140361-12-048273)

Filing Details

Accession Number:: 0001140361-12-048273
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2012-11-20 16:26:57
Reporting Period:: 2012-11-16

Filing Date:: 2012-11-20
Accepted Time:: 2012-11-20 16:26:57
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
315545	Provectus Pharmaceuticals Inc	PVCT	Pharmaceutical Preparations (2834)	900031917

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1124261	Phd Eric Wachter	7327 Oak Ridge Highway, Suite A Knoxville TN 37931	Chief Technology Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2012-11-16	666,666	$0.00	5,393,236	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Common Stock Warrants (right to buy)	Acquisiton	2012-11-16	666,666	$0.00	666,666	$1.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
666,666	2012-11-16	2017-11-16	No	4	P	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	4,867	Indirect	By Trust

Footnotes

The reported securities were purchased together, such that the purchase price for each share of common stock together with a warrant to purchase a share of common stock is $0.75.